These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3671877)

  • 1. Bremazocine-induced urination in rats of different sizes.
    Leander JD
    Res Commun Chem Pathol Pharmacol; 1987 Jul; 57(1):141-4. PubMed ID: 3671877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
    Salas SP; Roblero J; Ureta H; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):992-9. PubMed ID: 2550625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the kappa-agonist bremazocine on ingestive behaviour in mice and rats.
    Hartig U; Opitz K
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):4-12. PubMed ID: 6307194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of the development of postural asymmetry in rats as affected by the opioids met-enkephalin and the kappa-agonist bremazocine].
    Kobylianskiĭ AG; Bakalkin GIa
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1987; 37(6):1131-9. PubMed ID: 3448843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bremazocine on passive avoidance behaviour in mice.
    Castellano C; Pavone F
    Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):199-208. PubMed ID: 3789883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bremazocine on locomotor activity in DBA/2 and C57BL/6 mice.
    Castellano C; Pavone F
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):45-52. PubMed ID: 4096608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethylketocyclazocine and bremazocine analgesia in neonatal rats.
    Helmstetter FJ; Calcagnetti DJ; Cramer CP; Fanselow MS
    Pharmacol Biochem Behav; 1988 Aug; 30(4):817-21. PubMed ID: 3067243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa-opiates and urination: pharmacological evidence for an endogenous role of the kappa-opiate receptor in fluid and electrolyte balance.
    Huidobro-Toro JP; Parada S
    Eur J Pharmacol; 1984 Dec; 107(1):1-10. PubMed ID: 6098480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the respiratory depressant and analgesic effects of bremazocine, a kappa-agonist.
    Pazos A; Tristán C; Flórez J
    Life Sci; 1983; 33 Suppl 1():579-81. PubMed ID: 6319913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of serum corticosterone in rats by bremazocine, a kappa-opioid agonist.
    Fuller RW; Leander JD
    J Pharm Pharmacol; 1984 May; 36(5):345-6. PubMed ID: 6145778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bremazocine: an opiate that induces sedation and analgesia without respiratory depression.
    Freye E; Hartung E; Schenk GK
    Anesth Analg; 1983 May; 62(5):483-8. PubMed ID: 6301311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that bremazocine prevents urine retention induced by intraspinal cord injection of colchicine in rats.
    Zanoli P; Baraldi M
    J Auton Nerv Syst; 1990 Jul; 30 Suppl():S191-3. PubMed ID: 2170490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ability of the opiate kappa-agonist bremazocine to facilitate the flexor reflex of the right hindlimb in spinal rats].
    Tsibul'skiĭ VL; Kobylianskiĭ AG; Bakalkin GIa
    Biull Eksp Biol Med; 1988 Jan; 105(1):6-9. PubMed ID: 3337883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic effect of a kappa-opioid receptor agonist on plasma oxytocin levels in rats.
    Grell S; Fjalland B; Christensen JD
    Eur J Pharmacol; 1989 Jul; 166(1):41-8. PubMed ID: 2553430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus properties of bremazocine in the rat.
    Shearman GT; Herz A
    Neuropharmacology; 1981 Dec; 20(12A):1209-13. PubMed ID: 7322297
    [No Abstract]   [Full Text] [Related]  

  • 17. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist.
    Russell KR; Wang DR; Potter DE
    Exp Eye Res; 2000 May; 70(5):675-82. PubMed ID: 10870526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of nociceptive flexion reflex discharge by the kappa agonist bremazocine.
    Banna NR; Al-Amin HA; Jabbur SJ
    Neuropharmacology; 1987; 26(2-3):271-4. PubMed ID: 3035416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kappa opioid effect: increased urination in the rat.
    Leander JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.